M J Watt1, A C Barnett2, C R Bruce2,3, S Schenk4,5, J F Horowitz4, A J Hoy6,7. 1. Department of Physiology, Monash University, Building 13F, Clayton, VIC, 3800, Australia. matthew.watt@monash.edu. 2. Department of Physiology, Monash University, Building 13F, Clayton, VIC, 3800, Australia. 3. Baker IDI Heart & Diabetes Institute, Melbourne, VIC, Australia. 4. School of Kinesiology, University of Michigan, Ann Arbor, MI, USA. 5. Department of Orthopaedic Surgery, University of California, San Diego, CA, USA. 6. Department of Physiology, Monash University, Building 13F, Clayton, VIC, 3800, Australia. andrew.hoy@sydney.edu.au. 7. Discipline of Physiology, University of Sydney, Anderson Stuart Building (F13), Sydney, NSW, 2006, Australia. andrew.hoy@sydney.edu.au.
Abstract
AIMS/HYPOTHESIS: Plasma ceramide concentrations correlate with insulin sensitivity, inflammation and atherosclerotic risk. We hypothesised that plasma ceramide concentrations are increased in the presence of elevated fatty acid levels and are regulated by increased liver serine C-palmitoyltransferase (SPT) activity. METHODS: Lean humans and rats underwent an acute lipid infusion and plasma ceramide levels were determined. One group of lipid-infused rats was administered myriocin to inhibit SPT activity. Liver SPT activity was determined in lipid-infused rats, and obese, insulin resistant mice. The time and palmitate dose-dependent synthesis of intracellular and secreted ceramide was determined in HepG2 liver cells. RESULTS: Plasma ceramide levels were increased during lipid infusion in humans and rats, and in obese, insulin-resistant mice. The increase in plasma ceramide was not associated with changes in liver SPT activity, and inhibiting SPT activity by ~50% did not alter plasma ceramide levels in lipid-infused rats. In HepG2 liver cells, palmitate incorporation into extracellular ceramide was both dose- and time-dependent, suggesting the liver cells rapidly secreted the newly synthesised ceramide. CONCLUSIONS/ INTERPRETATION: Elevated systemic fatty acid availability increased plasma ceramide but this was not associated with changes in hepatic SPT activity, suggesting that liver ceramide synthesis is driven by substrate availability rather than increased SPT activity. This report also provides evidence that the liver is sensitive to the intracellular ceramide concentration, and an increase in liver ceramide secretion may help protect the liver from the deleterious effects of intracellular ceramide accumulation.
AIMS/HYPOTHESIS: Plasma ceramide concentrations correlate with insulin sensitivity, inflammation and atherosclerotic risk. We hypothesised that plasma ceramide concentrations are increased in the presence of elevated fatty acid levels and are regulated by increased liver serine C-palmitoyltransferase (SPT) activity. METHODS: Lean humans and rats underwent an acute lipid infusion and plasma ceramide levels were determined. One group of lipid-infused rats was administered myriocin to inhibit SPT activity. Liver SPT activity was determined in lipid-infused rats, and obese, insulin resistant mice. The time and palmitate dose-dependent synthesis of intracellular and secreted ceramide was determined in HepG2 liver cells. RESULTS: Plasma ceramide levels were increased during lipid infusion in humans and rats, and in obese, insulin-resistant mice. The increase in plasma ceramide was not associated with changes in liver SPT activity, and inhibiting SPT activity by ~50% did not alter plasma ceramide levels in lipid-infused rats. In HepG2 liver cells, palmitate incorporation into extracellular ceramide was both dose- and time-dependent, suggesting the liver cells rapidly secreted the newly synthesised ceramide. CONCLUSIONS/ INTERPRETATION: Elevated systemicfatty acid availability increased plasma ceramide but this was not associated with changes in hepatic SPT activity, suggesting that liver ceramide synthesis is driven by substrate availability rather than increased SPT activity. This report also provides evidence that the liver is sensitive to the intracellular ceramide concentration, and an increase in liver ceramide secretion may help protect the liver from the deleterious effects of intracellular ceramide accumulation.
Authors: Markus F Rütti; Stéphane Richard; Anke Penno; Arnold von Eckardstein; Thorsten Hornemann Journal: J Lipid Res Date: 2009-01-29 Impact factor: 5.922
Authors: V D F de Mello; M Lankinen; U Schwab; M Kolehmainen; S Lehto; T Seppänen-Laakso; M Oresic; L Pulkkinen; M Uusitupa; A T Erkkilä Journal: Diabetologia Date: 2009-08-11 Impact factor: 10.122
Authors: William L Holland; Joseph T Brozinick; Li-Ping Wang; Eric D Hawkins; Katherine M Sargent; Yanqi Liu; Krishna Narra; Kyle L Hoehn; Trina A Knotts; Angela Siesky; Don H Nelson; Sotirios K Karathanasis; Greg K Fontenot; Morris J Birnbaum; Scott A Summers Journal: Cell Metab Date: 2007-03 Impact factor: 27.287
Authors: Lascelles E Lyn-Cook; Margot Lawton; Ming Tong; Elizabeth Silbermann; Lisa Longato; Ping Jiao; Princess Mark; Jack R Wands; Haiyan Xu; Suzanne M de la Monte Journal: J Alzheimers Dis Date: 2009 Impact factor: 4.472
Authors: Jacob M Haus; Sangeeta R Kashyap; Takhar Kasumov; Renliang Zhang; Karen R Kelly; Ralph A Defronzo; John P Kirwan Journal: Diabetes Date: 2008-11-13 Impact factor: 9.461
Authors: B D Kayser; M Lhomme; M C Dao; F Ichou; J-L Bouillot; E Prifti; A Kontush; J-M Chevallier; J Aron-Wisnewsky; I Dugail; K Clément Journal: Int J Obes (Lond) Date: 2017-03-10 Impact factor: 5.095
Authors: Takhar Kasumov; Thomas P J Solomon; Calvin Hwang; Hazel Huang; Jacob M Haus; Renliang Zhang; John P Kirwan Journal: Obesity (Silver Spring) Date: 2015-05-12 Impact factor: 5.002
Authors: D Lee Gorden; David S Myers; Pavlina T Ivanova; Eoin Fahy; Mano R Maurya; Shakti Gupta; Jun Min; Nathanael J Spann; Jeffrey G McDonald; Samuel L Kelly; Jingjing Duan; M Cameron Sullards; Thomas J Leiker; Robert M Barkley; Oswald Quehenberger; Aaron M Armando; Stephen B Milne; Thomas P Mathews; Michelle D Armstrong; Chijun Li; Willie V Melvin; Ronald H Clements; M Kay Washington; Alisha M Mendonsa; Joseph L Witztum; Ziqiang Guan; Christopher K Glass; Robert C Murphy; Edward A Dennis; Alfred H Merrill; David W Russell; Shankar Subramaniam; H Alex Brown Journal: J Lipid Res Date: 2015-01-17 Impact factor: 5.922
Authors: Jason M Correnti; Egle Juskeviciute; Aditi Swarup; Jan B Hoek Journal: Am J Physiol Gastrointest Liver Physiol Date: 2014-04-17 Impact factor: 4.052